![]() |
Basic Information |
![]() |
Post buying leads |
![]() |
Suppliers |
Name |
Tolazoline hydrochloride |
EINECS | 200-447-3 |
CAS No. | 59-97-2 | Density | 1.09g/cm3 |
PSA | 24.39000 | LogP | 1.79720 |
Solubility | N/A | Melting Point |
172-176 °C |
Formula | C10H12N2.HCl | Boiling Point | 338.2 °C at 760 mmHg |
Molecular Weight | 196.68 | Flash Point | 158.3 °C |
Transport Information | N/A | Appearance | Pale yellow crystalline solid |
Safety | 22 | Risk Codes | 22 |
Molecular Structure |
|
Hazard Symbols |
![]() |
Synonyms |
1H-Imidazole,4,5-dihydro-2-(phenylmethyl)-, monohydrochloride (9CI);2-Imidazoline, 2-benzyl-,monohydrochloride (8CI);2-Benzyl-2-imidazoline hydrochloride;2-Benzyl-4,5-dihydroimidazole hydrochloride;2-Benzylimidazoline hydrochloride;Arterodyl;Benzazoline hydrochloride;Imidaline hydrochloride;Lambral;Priscoline hydrochloride;Tolavad;Tolazoline chloride;Tolazolinehydrochloride;Tolpal;Totazoline;Vaso-Dilatan; |
Reported in EPA TSCA Inventory.
The Benzazoline hydrochloride is an organic compound with the formula C10H12N2.HCl. The IUPAC name of this chemical is 2-benzyl-4,5-dihydro-1H-imidazole hydrochloride. With the CAS registry number 59-97-2, it is also named as (4-chlorophenyl)piperazine. The product's categories are Intermediates & Fine Chemicals; Pharmaceuticals. Besides, it is a pale yellow crystalline solid, which should be stored in a closed place. It is used for biological research and medicine.
Physical properties about Benzazoline hydrochloride are: (1)ACD/LogP: 1.84; (2)ACD/LogD (pH 5.5): -0.91; (3)ACD/LogD (pH 7.4): 0.71; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1.09; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 17.58; (8)#H bond acceptors: 2; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 1; (11)Polar Surface Area: 6.48 Å2; (12)Index of Refraction: 1.557; (13)Molar Refractivity: 54.7 cm3; (14)Molar Volume: 169.6 cm3; (15)Polarizability: 21.68×10-24cm3; (16)Surface Tension: 39.7 dyne/cm; (17)Density: 1.159 g/cm3; (18)Flash Point: 157.2 °C; (19)Enthalpy of Vaporization: 57.94 kJ/mol; (20)Boiling Point: 336.3 °C at 760 mmHg; (21)Vapour Pressure: 0.000113 mmHg at 25°C.
Uses of Benzazoline hydrochloride: it can be used to produce (1H-imidazol-2-yl)-phenyl-methanone by heating. It will need reagent sodium acetate, KMnO4 and solvent dioxane with reaction time of 24 hours. The yield is about 42%.
When you are using this chemical, please be cautious about it as the following:
This chemical is harmful if swallowed. When you are using it, do not breathe dust.
You can still convert the following datas into molecular structure:
(1)SMILES: Clc1ccc(cc1)N2CCNCC2
(2)InChI: InChI=1/C10H13ClN2/c11-9-1-3-10(4-2-9)13-7-5-12-6-8-13/h1-4,12H,5-8H2
(3)InChIKey: UNEIHNMKASENIG-UHFFFAOYAT
(4)Std. InChI: InChI=1S/C10H13ClN2/c11-9-1-3-10(4-2-9)13-7-5-12-6-8-13/h1-4,12H,5-8H2
(5)Std. InChIKey: UNEIHNMKASENIG-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
human | TDLo | intravenous | 150ug/kg (0.15mg/kg) | CARDIAC: CHANGE IN RATE VASCULAR: OTHER CHANGES SKIN AND APPENDAGES (SKIN): SWEATING: OTHER | Folia Medica Vol. 27, Pg. 729, 1941. |
infant | TDLo | intravenous | 48mg/kg/47H-C (48mg/kg) | GASTROINTESTINAL: ULCERATION OR BLEEDING FROM DUODENUM GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE | Australian Paediatric Journal. Vol. 22, Pg. 221, 1986. |
mouse | LD50 | intraperitoneal | 130mg/kg (130mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1992, 1971. |
mouse | LD50 | intravenous | 56700ug/kg (56.7mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Journal of Pharmacobio-Dynamics. Vol. 9, Pg. 395, 1986. |
mouse | LD50 | oral | 400mg/kg (400mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1992, 1971. |
rat | LD50 | intraperitoneal | 100mg/kg (100mg/kg) | Drugs in Japan Vol. 6, Pg. 511, 1982. | |
rat | LD50 | intravenous | 85mg/kg (85mg/kg) | Drugs in Japan Vol. 6, Pg. 511, 1982. | |
rat | LD50 | oral | 1200mg/kg (1200mg/kg) | Drugs in Japan Vol. 6, Pg. 511, 1982. |